Inactivated vaccine against Newcastle disease from “La-Sota” strain

Description

The vaccine is a homogenous white emulsion produced from extraembryonic fluid of chick embryos inoculated with NDV inactivated by aminoethylethanolamine with the addition of an oil adjuvant.

Indication

The vaccine is innocuous, highly immunogenic and is used in veterinary for specific prevention of Newcastle disease in pigeons on free and infected farms as well as on farms at risk.

Route of administration

Pigeons at the age of 35 days are subject to vaccination. Revaccination is carried out 6 months after the vaccination. Pedigree pigeons are vaccinated 25–30 prior to exhibition and newly introduced pigeons are vaccinated within the quarantine period. Adults are vaccinated annually, preferably 2–3 weeks prior to mating. The vaccine is injected intramuscularly in pectoral muscles in the volume of 0.25 cm3.

Immunity

Immunity against ND is induced 21 day after the single vaccination of pigeons and lasts for at least 6 months. Preclinical commissioning and laboratory test results demonstrated that “Pigeon-ND” vaccinated birds were protected from clinical signs of the disease and death following the enteric and intramuscular infection with virulent NDV strains: genotype VIId strain and VIb2 genotype isolate, on 21 day after the vaccination.

Storage conditions

The vaccine shelf-life is 12 months after the production date if it is stored (transported) in dry dark place at 2–8°C.

Documentation

Each vaccine batch is accompanied with a Certificate containing information of main physical, chemical and immunobiological properties.

Disease: 
Newcastle disease
Strain/ serotype: 
La-Sota
Appearance: 
inactivated
Filling/ dosage: 
5 cm3 bottle
Measurement unit: 
one thousand doses
Instructions: 
Certificates: